Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity
ObjectivesThe aims of this study were to define the pattern of muscle involvement in patients with immune-mediated necrotising myopathy (IMNM) relative to those with other inflammatory myopathies and to compare patients with IMNM with different autoantibodies.MethodsAll Johns Hopkins Myositis Longit...
Saved in:
Published in | Annals of the rheumatic diseases Vol. 76; no. 4; pp. 681 - 687 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Limited
01.04.2017
|
Subjects | |
Online Access | Get full text |
ISSN | 0003-4967 1468-2060 1468-2060 |
DOI | 10.1136/annrheumdis-2016-210198 |
Cover
Abstract | ObjectivesThe aims of this study were to define the pattern of muscle involvement in patients with immune-mediated necrotising myopathy (IMNM) relative to those with other inflammatory myopathies and to compare patients with IMNM with different autoantibodies.MethodsAll Johns Hopkins Myositis Longitudinal Cohort subjects with a thigh MRI (tMRI) who fulfilled criteria for IMNM, dermatomyositis (DM), polymyositis (PM), inclusion body myositis (IBM) or clinically amyopathic DM (CADM) were included in the study. Muscles were assessed for intramuscular and fascial oedema, atrophy and fatty replacement. Disease subgroups were compared using univariate and multivariate analyses. Patients with IMNM with anti-signal recognition particle (SRP) autoantibodies were compared with those with IMNM with anti-HMG-CoA reductase (HMGCR) autoantibodies.ResultsThe study included 666 subjects (101 IMNM, 176 PM, 219 DM, 17 CADM and 153 IBM). Compared with DM or PM, IMNM was characterised by a higher proportion of thigh muscles with oedema, atrophy and fatty replacement (p<0.01). Patients with IMNM with anti-SRP had more atrophy (19%, p=0.003) and fatty replacement (18%, p=0.04) than those with anti-HMGCR. In IMNM, muscle abnormalities were especially common in the lateral rotator and gluteal groups. Fascial involvement was most widespread in DM. Fatty replacement of muscle tissue began early during the course of disease in IMNM and the other groups. An optimal combination of tMRI features had only a 55% positive predictive value for diagnosing IMNM.ConclusionsCompared with patients with DM or PM, IMNM is characterised by more widespread muscle involvement. Anti-SRP-positive patients have more severe muscle involvement than anti-HMGCR-positive patients. |
---|---|
AbstractList | The aims of this study were to define the pattern of muscle involvement in patients with immune-mediated necrotising myopathy (IMNM) relative to those with other inflammatory myopathies and to compare patients with IMNM with different autoantibodies.OBJECTIVESThe aims of this study were to define the pattern of muscle involvement in patients with immune-mediated necrotising myopathy (IMNM) relative to those with other inflammatory myopathies and to compare patients with IMNM with different autoantibodies.All Johns Hopkins Myositis Longitudinal Cohort subjects with a thigh MRI (tMRI) who fulfilled criteria for IMNM, dermatomyositis (DM), polymyositis (PM), inclusion body myositis (IBM) or clinically amyopathic DM (CADM) were included in the study. Muscles were assessed for intramuscular and fascial oedema, atrophy and fatty replacement. Disease subgroups were compared using univariate and multivariate analyses. Patients with IMNM with anti-signal recognition particle (SRP) autoantibodies were compared with those with IMNM with anti-HMG-CoA reductase (HMGCR) autoantibodies.METHODSAll Johns Hopkins Myositis Longitudinal Cohort subjects with a thigh MRI (tMRI) who fulfilled criteria for IMNM, dermatomyositis (DM), polymyositis (PM), inclusion body myositis (IBM) or clinically amyopathic DM (CADM) were included in the study. Muscles were assessed for intramuscular and fascial oedema, atrophy and fatty replacement. Disease subgroups were compared using univariate and multivariate analyses. Patients with IMNM with anti-signal recognition particle (SRP) autoantibodies were compared with those with IMNM with anti-HMG-CoA reductase (HMGCR) autoantibodies.The study included 666 subjects (101 IMNM, 176 PM, 219 DM, 17 CADM and 153 IBM). Compared with DM or PM, IMNM was characterised by a higher proportion of thigh muscles with oedema, atrophy and fatty replacement (p<0.01). Patients with IMNM with anti-SRP had more atrophy (19%, p=0.003) and fatty replacement (18%, p=0.04) than those with anti-HMGCR. In IMNM, muscle abnormalities were especially common in the lateral rotator and gluteal groups. Fascial involvement was most widespread in DM. Fatty replacement of muscle tissue began early during the course of disease in IMNM and the other groups. An optimal combination of tMRI features had only a 55% positive predictive value for diagnosing IMNM.RESULTSThe study included 666 subjects (101 IMNM, 176 PM, 219 DM, 17 CADM and 153 IBM). Compared with DM or PM, IMNM was characterised by a higher proportion of thigh muscles with oedema, atrophy and fatty replacement (p<0.01). Patients with IMNM with anti-SRP had more atrophy (19%, p=0.003) and fatty replacement (18%, p=0.04) than those with anti-HMGCR. In IMNM, muscle abnormalities were especially common in the lateral rotator and gluteal groups. Fascial involvement was most widespread in DM. Fatty replacement of muscle tissue began early during the course of disease in IMNM and the other groups. An optimal combination of tMRI features had only a 55% positive predictive value for diagnosing IMNM.Compared with patients with DM or PM, IMNM is characterised by more widespread muscle involvement. Anti-SRP-positive patients have more severe muscle involvement than anti-HMGCR-positive patients.CONCLUSIONSCompared with patients with DM or PM, IMNM is characterised by more widespread muscle involvement. Anti-SRP-positive patients have more severe muscle involvement than anti-HMGCR-positive patients. ObjectivesThe aims of this study were to define the pattern of muscle involvement in patients with immune-mediated necrotising myopathy (IMNM) relative to those with other inflammatory myopathies and to compare patients with IMNM with different autoantibodies.MethodsAll Johns Hopkins Myositis Longitudinal Cohort subjects with a thigh MRI (tMRI) who fulfilled criteria for IMNM, dermatomyositis (DM), polymyositis (PM), inclusion body myositis (IBM) or clinically amyopathic DM (CADM) were included in the study. Muscles were assessed for intramuscular and fascial oedema, atrophy and fatty replacement. Disease subgroups were compared using univariate and multivariate analyses. Patients with IMNM with anti-signal recognition particle (SRP) autoantibodies were compared with those with IMNM with anti-HMG-CoA reductase (HMGCR) autoantibodies.ResultsThe study included 666 subjects (101 IMNM, 176 PM, 219 DM, 17 CADM and 153 IBM). Compared with DM or PM, IMNM was characterised by a higher proportion of thigh muscles with oedema, atrophy and fatty replacement (p<0.01). Patients with IMNM with anti-SRP had more atrophy (19%, p=0.003) and fatty replacement (18%, p=0.04) than those with anti-HMGCR. In IMNM, muscle abnormalities were especially common in the lateral rotator and gluteal groups. Fascial involvement was most widespread in DM. Fatty replacement of muscle tissue began early during the course of disease in IMNM and the other groups. An optimal combination of tMRI features had only a 55% positive predictive value for diagnosing IMNM.ConclusionsCompared with patients with DM or PM, IMNM is characterised by more widespread muscle involvement. Anti-SRP-positive patients have more severe muscle involvement than anti-HMGCR-positive patients. Objectives The aims of this study were to define the pattern of muscle involvement in patients with immune-mediated necrotising myopathy (IMNM) relative to those with other inflammatory myopathies and to compare patients with IMNM with different autoantibodies. Methods All Johns Hopkins Myositis Longitudinal Cohort subjects with a thigh MRI (tMRI) who fulfilled criteria for IMNM, dermatomyositis (DM), polymyositis (PM), inclusion body myositis (IBM) or clinically amyopathic DM (CADM) were included in the study. Muscles were assessed for intramuscular and fascial oedema, atrophy and fatty replacement. Disease subgroups were compared using univariate and multivariate analyses. Patients with IMNM with anti-signal recognition particle (SRP) autoantibodies were compared with those with IMNM with anti-HMG-CoA reductase (HMGCR) autoantibodies. Results The study included 666 subjects (101 IMNM, 176 PM, 219 DM, 17 CADM and 153 IBM). Compared with DM or PM, IMNM was characterised by a higher proportion of thigh muscles with oedema, atrophy and fatty replacement (p<0.01). Patients with IMNM with anti-SRP had more atrophy (19%, p=0.003) and fatty replacement (18%, p=0.04) than those with anti-HMGCR. In IMNM, muscle abnormalities were especially common in the lateral rotator and gluteal groups. Fascial involvement was most widespread in DM. Fatty replacement of muscle tissue began early during the course of disease in IMNM and the other groups. An optimal combination of tMRI features had only a 55% positive predictive value for diagnosing IMNM. Conclusions Compared with patients with DM or PM, IMNM is characterised by more widespread muscle involvement. Anti-SRP-positive patients have more severe muscle involvement than anti-HMGCR-positive patients. The aims of this study were to define the pattern of muscle involvement in patients with immune-mediated necrotising myopathy (IMNM) relative to those with other inflammatory myopathies and to compare patients with IMNM with different autoantibodies. All Johns Hopkins Myositis Longitudinal Cohort subjects with a thigh MRI (tMRI) who fulfilled criteria for IMNM, dermatomyositis (DM), polymyositis (PM), inclusion body myositis (IBM) or clinically amyopathic DM (CADM) were included in the study. Muscles were assessed for intramuscular and fascial oedema, atrophy and fatty replacement. Disease subgroups were compared using univariate and multivariate analyses. Patients with IMNM with anti-signal recognition particle (SRP) autoantibodies were compared with those with IMNM with anti-HMG-CoA reductase (HMGCR) autoantibodies. The study included 666 subjects (101 IMNM, 176 PM, 219 DM, 17 CADM and 153 IBM). Compared with DM or PM, IMNM was characterised by a higher proportion of thigh muscles with oedema, atrophy and fatty replacement (p<0.01). Patients with IMNM with anti-SRP had more atrophy (19%, p=0.003) and fatty replacement (18%, p=0.04) than those with anti-HMGCR. In IMNM, muscle abnormalities were especially common in the lateral rotator and gluteal groups. Fascial involvement was most widespread in DM. Fatty replacement of muscle tissue began early during the course of disease in IMNM and the other groups. An optimal combination of tMRI features had only a 55% positive predictive value for diagnosing IMNM. Compared with patients with DM or PM, IMNM is characterised by more widespread muscle involvement. Anti-SRP-positive patients have more severe muscle involvement than anti-HMGCR-positive patients. |
Author | Albayda, Jemima Paik, Julie J Ahlawat, Shivani Danoff, Sonye K Mammen, Andrew L Lahouti, Arash H Lloyd, Thomas E Pinal-Fernandez, Iago Christopher-Stine, Lisa Casal-Dominguez, Maria Carrino, John A Basharat, Pari |
AuthorAffiliation | 1 National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA 2 Johns Hopkins University School of Medicine, Baltimore, Maryland, USA |
AuthorAffiliation_xml | – name: 2 Johns Hopkins University School of Medicine, Baltimore, Maryland, USA – name: 1 National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA |
Author_xml | – sequence: 1 givenname: Iago surname: Pinal-Fernandez fullname: Pinal-Fernandez, Iago email: iagopf@yahoo.es, andrew.mammen@nih.gov organization: National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA – sequence: 2 givenname: Maria surname: Casal-Dominguez fullname: Casal-Dominguez, Maria email: iagopf@yahoo.es, andrew.mammen@nih.gov organization: Johns Hopkins University School of Medicine, Baltimore, Maryland, USA – sequence: 3 givenname: John A orcidid: 0000-0003-3472-2469 surname: Carrino fullname: Carrino, John A email: iagopf@yahoo.es, andrew.mammen@nih.gov organization: Johns Hopkins University School of Medicine, Baltimore, Maryland, USA – sequence: 4 givenname: Arash H surname: Lahouti fullname: Lahouti, Arash H email: iagopf@yahoo.es, andrew.mammen@nih.gov organization: Johns Hopkins University School of Medicine, Baltimore, Maryland, USA – sequence: 5 givenname: Pari surname: Basharat fullname: Basharat, Pari email: iagopf@yahoo.es, andrew.mammen@nih.gov organization: Johns Hopkins University School of Medicine, Baltimore, Maryland, USA – sequence: 6 givenname: Jemima surname: Albayda fullname: Albayda, Jemima email: iagopf@yahoo.es, andrew.mammen@nih.gov organization: Johns Hopkins University School of Medicine, Baltimore, Maryland, USA – sequence: 7 givenname: Julie J surname: Paik fullname: Paik, Julie J email: iagopf@yahoo.es, andrew.mammen@nih.gov organization: Johns Hopkins University School of Medicine, Baltimore, Maryland, USA – sequence: 8 givenname: Shivani surname: Ahlawat fullname: Ahlawat, Shivani email: iagopf@yahoo.es, andrew.mammen@nih.gov organization: Johns Hopkins University School of Medicine, Baltimore, Maryland, USA – sequence: 9 givenname: Sonye K surname: Danoff fullname: Danoff, Sonye K email: iagopf@yahoo.es, andrew.mammen@nih.gov organization: Johns Hopkins University School of Medicine, Baltimore, Maryland, USA – sequence: 10 givenname: Thomas E surname: Lloyd fullname: Lloyd, Thomas E email: iagopf@yahoo.es, andrew.mammen@nih.gov organization: Johns Hopkins University School of Medicine, Baltimore, Maryland, USA – sequence: 11 givenname: Andrew L surname: Mammen fullname: Mammen, Andrew L email: iagopf@yahoo.es, andrew.mammen@nih.gov organization: Johns Hopkins University School of Medicine, Baltimore, Maryland, USA – sequence: 12 givenname: Lisa surname: Christopher-Stine fullname: Christopher-Stine, Lisa email: iagopf@yahoo.es, andrew.mammen@nih.gov organization: Johns Hopkins University School of Medicine, Baltimore, Maryland, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27651398$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkl1rFDEUhoNU7Hb1L2jAGy8czeckI1SQ4kehotR6PWRmzuxmnUnWJLO4v8U_a4ZtS-1VIZCc5HlPTk7eE3TkvAOEXlDyhlJevjXOhTVMY2djwQgtC0YJrfQjtKCi1HmrJEdoQQjhhahKdYxOYtzkkGiqn6BjpkpJeaUX6O_V2q7WeJxiOwD-enmOrcN2HCcHxQidNQk67KANPtlo3QqPe781ab1_h-FPAhftDrCHDkbzGoMJw_4mV2dGswJsXIeDz7Hv8zrZ4sfld2ym5Oeg8Z2FiE0eeDThF4QZi7CDYNP-KXrcmyHCs-t5iX5--nh19qW4-Pb5_OzDRdFIrVKhWsJM2XIhldDc6IYypqlQhknWl7TrZcVEJRvVM9EJ3TIOkgulqBISWqn4Er0_5N1OTX5zCy4FM9TbYHNN-9obW_9_4uy6XvldXeaey9zIJXp1nSD43xPEVI82tjAMxoGfYk21pkqqjD8A5ZIronmZ0Zf30I2fgsudmBOyikghWKae3y3-tuqbL86AOgD5D2MM0N8ilNSzmeo7ZqpnM9UHM2Xl6T1la5NJ1s9dsMMD9Oygb8bNgy_9B3dK5no |
CODEN | ARDIAO |
CitedBy_id | crossref_primary_10_1016_S2665_9913_23_00322_3 crossref_primary_10_2147_JIR_S270114 crossref_primary_10_1371_journal_pone_0184059 crossref_primary_10_1016_j_autrev_2018_09_008 crossref_primary_10_1016_j_jbspin_2019_01_013 crossref_primary_10_1093_rheumatology_keab900 crossref_primary_10_1093_rheumatology_keab629 crossref_primary_10_2214_AJR_20_23045 crossref_primary_10_1111_cns_14647 crossref_primary_10_1177_20584601221075796 crossref_primary_10_1186_s12891_023_06354_5 crossref_primary_10_1590_0004_282x_anp_2022_s131 crossref_primary_10_3899_jrheum_171495 crossref_primary_10_1097_WCO_0000000000000740 crossref_primary_10_1212_CON_0000000000000789 crossref_primary_10_1212_WNL_0000000000005638 crossref_primary_10_1007_s40674_023_00210_2 crossref_primary_10_3389_fneur_2023_1123380 crossref_primary_10_1093_rheumatology_keac269 crossref_primary_10_1007_s00415_024_12191_w crossref_primary_10_1212_NXI_0000000000000523 crossref_primary_10_1007_s11926_018_0763_z crossref_primary_10_1080_10408363_2021_2000584 crossref_primary_10_4078_jrd_2020_27_3_136 crossref_primary_10_1016_S1474_4422_18_30254_0 crossref_primary_10_2169_internalmedicine_8554_21 crossref_primary_10_1007_s00415_024_12544_5 crossref_primary_10_3389_fimmu_2024_1439807 crossref_primary_10_1007_s10067_024_07240_8 crossref_primary_10_1007_s00393_024_01523_w crossref_primary_10_1136_annrheumdis_2018_214644 crossref_primary_10_1016_j_semarthrit_2019_04_002 crossref_primary_10_1002_mus_26660 crossref_primary_10_1007_s00415_022_11447_7 crossref_primary_10_1002_acr_23188 crossref_primary_10_1007_s11910_020_01064_0 crossref_primary_10_1002_mus_27382 crossref_primary_10_1080_20009666_2019_1571882 crossref_primary_10_1007_s11926_018_0732_6 crossref_primary_10_2301_neurosonology_37_21 crossref_primary_10_1097_BOR_0000000000000549 crossref_primary_10_1097_BOR_0000000000000547 crossref_primary_10_1002_mus_27825 crossref_primary_10_1007_s11926_019_0864_3 crossref_primary_10_1007_s13311_018_00676_2 crossref_primary_10_2169_internalmedicine_2583_23 crossref_primary_10_1212_NXI_0000000000200285 crossref_primary_10_1097_BOR_0000000000000540 crossref_primary_10_1002_mus_26731 crossref_primary_10_1016_j_nmd_2023_08_014 crossref_primary_10_3389_fimmu_2025_1455867 crossref_primary_10_1002_mus_28114 crossref_primary_10_1212_WNL_0000000000004923 crossref_primary_10_1016_j_pediatrneurol_2025_03_002 crossref_primary_10_3389_fimmu_2022_1019972 crossref_primary_10_3389_fneur_2023_1251025 crossref_primary_10_1038_s41584_020_00515_9 crossref_primary_10_3390_ijms23084301 crossref_primary_10_1007_s00296_019_04254_3 crossref_primary_10_14412_1996_7012_2019_1_95_100 crossref_primary_10_1016_j_rdc_2024_07_005 crossref_primary_10_1016_j_semarthrit_2025_152672 crossref_primary_10_1097_BOR_0000000000000832 crossref_primary_10_1111_nan_12457 crossref_primary_10_1111_ene_15174 crossref_primary_10_1080_24725625_2017_1320466 crossref_primary_10_1097_BOR_0000000000000435 crossref_primary_10_1016_j_jot_2023_07_005 crossref_primary_10_1038_nrrheum_2017_1 crossref_primary_10_1073_pnas_2217831120 crossref_primary_10_7759_cureus_10916 crossref_primary_10_1093_rheumatology_kead174 crossref_primary_10_1007_s11910_023_01250_w crossref_primary_10_1136_annrheumdis_2018_213518 crossref_primary_10_1007_s40674_023_00201_3 crossref_primary_10_1093_omcr_omad097 crossref_primary_10_2482_haigan_61_322 crossref_primary_10_1007_s11926_020_00939_y crossref_primary_10_1111_bpa_12954 crossref_primary_10_4103_0366_6999_222323 crossref_primary_10_1007_s00256_019_03175_3 crossref_primary_10_7759_cureus_81018 crossref_primary_10_1016_j_berh_2022_101762 crossref_primary_10_1016_j_nmd_2024_105257 crossref_primary_10_7759_cureus_40825 crossref_primary_10_1016_S1634_7072_20_43301_X crossref_primary_10_1177_14782715241300850 crossref_primary_10_1007_s11910_024_01337_y crossref_primary_10_1111_cen3_12831 crossref_primary_10_2214_AJR_24_31359 crossref_primary_10_1093_rheumatology_keae125 crossref_primary_10_1111_ncn3_12578 crossref_primary_10_3233_JND_221557 crossref_primary_10_1007_s10140_020_01866_2 crossref_primary_10_1016_j_nmd_2017_09_016 crossref_primary_10_3988_jcn_2024_0333 crossref_primary_10_3389_fneur_2021_670784 crossref_primary_10_1136_rmdopen_2018_000850 crossref_primary_10_1186_s13075_019_2093_6 crossref_primary_10_1038_s41584_019_0223_9 crossref_primary_10_1080_03009742_2023_2202510 crossref_primary_10_1007_s00256_021_03728_5 crossref_primary_10_1007_s40674_021_00174_1 crossref_primary_10_3390_antib13010012 crossref_primary_10_1016_j_nmd_2021_11_010 crossref_primary_10_1016_j_revmed_2020_10_379 crossref_primary_10_1038_s41598_021_89311_3 crossref_primary_10_1093_rheumatology_keaa274 crossref_primary_10_2174_1573397114666180406101850 crossref_primary_10_1093_rheumatology_kez642 crossref_primary_10_18214_jend_2022_00087 crossref_primary_10_1093_mr_roae070 crossref_primary_10_1186_s13550_017_0348_2 crossref_primary_10_1016_j_semarthrit_2020_02_009 crossref_primary_10_1016_S0001_4079_19_30341_3 crossref_primary_10_1136_practneurol_2017_001848 crossref_primary_10_17650_2222_8721_2023_13_2_72_82 crossref_primary_10_1007_s11739_019_02112_5 crossref_primary_10_1007_s11926_019_0807_z crossref_primary_10_1002_mus_26375 crossref_primary_10_1002_eji_202250326 crossref_primary_10_1007_s11547_020_01317_5 crossref_primary_10_1016_j_nmd_2020_08_360 crossref_primary_10_1007_s40674_023_00214_y crossref_primary_10_7759_cureus_27824 crossref_primary_10_1097_CND_0000000000000487 crossref_primary_10_1007_s40674_017_0080_0 crossref_primary_10_1016_j_nrl_2023_03_005 crossref_primary_10_1016_j_chest_2021_03_040 crossref_primary_10_46833_reumatologiasp_2017_16_4_31_38 crossref_primary_10_1007_s00256_018_3107_1 crossref_primary_10_3390_diagnostics13142316 crossref_primary_10_5692_clinicalneurol_cn_001201 crossref_primary_10_1093_rheumatology_keac286 |
Cites_doi | 10.1093/rheumatology/ker001 10.2214/AJR.08.1764 10.1007/s002560000238 10.1056/NEJMc1506827 10.1002/mus.24661 10.1016/j.nmd.2004.02.006 10.1097/BOR.0b013e3282efdc66 10.2214/ajr.179.4.1790967 10.1002/acr.20219 10.1002/mus.24307 10.1067/mjd.2002.120621 10.1002/(SICI)1099-1255(199611)11:6<619::AID-JAE418>3.0.CO;2-1 10.1093/rheumatology/kev344 10.1056/NEJM197502202920807 10.1007/s00330-015-3783-3 10.1002/ana.410380504 10.1097/RMR.0b013e31825b2c35 10.1002/art.27704 10.1002/acr.20662 10.1093/rheumatology/keu422 |
ContentType | Journal Article |
Copyright | Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/. Copyright: 2016 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing |
Copyright_xml | – notice: Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing – notice: Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/. – notice: Copyright: 2016 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 88I 8AF 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI BTHHO CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9- K9. LK8 M0R M0S M1P M2P M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 7T5 H94 5PM |
DOI | 10.1136/annrheumdis-2016-210198 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Science Database (Alumni Edition) STEM Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection BMJ Journals ProQuest One ProQuest Central Korea Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Consumer Health Database Health & Medical Collection (Alumni) Medical Database Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic Immunology Abstracts AIDS and Cancer Research Abstracts PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest AP Science ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Family Health (Alumni Edition) ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition BMJ Journals ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic AIDS and Cancer Research Abstracts Immunology Abstracts |
DatabaseTitleList | MEDLINE - Academic AIDS and Cancer Research Abstracts ProQuest Central Student MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1468-2060 |
EndPage | 687 |
ExternalDocumentID | PMC6019551 4321357767 27651398 10_1136_annrheumdis_2016_210198 annrheumdis |
Genre | Journal Article Comparative Study |
GrantInformation_xml | – fundername: Intramural NIH HHS grantid: Z99 AR999999 |
GroupedDBID | --- .55 .GJ .VT 169 23M 2WC 39C 3O- 4.4 40O 53G 5GY 5RE 5VS 6J9 7X7 7~S 88E 88I 8AF 8FE 8FH 8FI 8FJ 8R4 8R5 AAHLL AAKAS AAOJX AAWJN AAWTL AAXUO ABAAH ABJNI ABKDF ABMQD ABOCM ABTFR ABUWG ABVAJ ACGFO ACGFS ACGOD ACGTL ACHTP ACMFJ ACOAB ACOFX ACPRK ACQSR ACTZY ADBBV ADCEG ADFRT ADUGQ ADZCM AEKJL AENEX AFKRA AFWFF AGQPQ AHMBA AHNKE AHQMW AJYBZ AKKEP ALIPV ALMA_UNASSIGNED_HOLDINGS ASPBG AVWKF AZFZN AZQEC BAWUL BBNVY BENPR BHPHI BKNYI BLJBA BOMFT BPHCQ BTFSW BTHHO BVXVI C1A C45 CAG CCPQU COF CS3 CXRWF DIK DWQXO E3Z EBS EJD F5P FDB FYUFA GNUQQ H13 HAJ HCIFZ HMCUK HYE HZ~ IAO IEA IHR INH INR IOF ITC J5H K9- KQ8 L7B LK8 M0R M1P M2P M7P N9A NTWIH NXWIF O9- OK1 OVD P2P PHGZT PQQKQ PROAC PSQYO Q2X R53 RHI RMJ RPM RV8 RWL RXW TAE TEORI TR2 UAW UKHRP UYXKK V24 VM9 VVN W2D W8F WH7 WOQ X6Y X7M YFH YOC YQY ZGI ZXP AAFWJ AALRI AAYXX CITATION PHGZM CGR CUY CVF ECM EIF NPM PJZUB PPXIY PQGLB 3V. 7XB 8FK K9. PKEHL PQEST PQUKI PRINS Q9U 0R~ 7X8 PUEGO 7T5 H94 5PM |
ID | FETCH-LOGICAL-b587t-7c02a6c3457483a8b1228147a252f61df592495b7f24d48c23e534771745ec573 |
IEDL.DBID | 7X7 |
ISSN | 0003-4967 1468-2060 |
IngestDate | Thu Aug 21 18:08:24 EDT 2025 Fri Sep 05 13:44:11 EDT 2025 Fri Sep 05 12:13:41 EDT 2025 Fri Jul 25 11:10:35 EDT 2025 Mon Jul 21 06:01:36 EDT 2025 Tue Jul 01 04:18:05 EDT 2025 Thu Apr 24 22:59:01 EDT 2025 Thu Apr 24 23:08:30 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Magnetic Resonance Imaging Polymyositis Autoantibodies Dermatomyositis |
Language | English |
License | Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b587t-7c02a6c3457483a8b1228147a252f61df592495b7f24d48c23e534771745ec573 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 IP-F and ALM are co-corresponding authors. IP-F, MC-D, ALM and LC-S contributed equally. |
ORCID | 0000-0003-3472-2469 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/6019551 |
PMID | 27651398 |
PQID | 1882905442 |
PQPubID | 2041045 |
PageCount | 7 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6019551 proquest_miscellaneous_1881757601 proquest_miscellaneous_1835370836 proquest_journals_1882905442 pubmed_primary_27651398 crossref_primary_10_1136_annrheumdis_2016_210198 crossref_citationtrail_10_1136_annrheumdis_2016_210198 bmj_primary_10_1136_annrheumdis_2016_210198 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-04-01 |
PublicationDateYYYYMMDD | 2017-04-01 |
PublicationDate_xml | – month: 04 year: 2017 text: 2017-04-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Kidlington |
PublicationTitle | Annals of the rheumatic diseases |
PublicationTitleAlternate | Ann Rheum Dis |
PublicationYear | 2017 |
Publisher | Elsevier Limited |
Publisher_xml | – name: Elsevier Limited |
References | Hoogendijk, Amato, Lecky 2004; 14 Del Grande, Carrino, Del Grande 2011; 22 Kuo, Carrino 2007; 19 Bohan, Peter 1975; 292 Cox, Reijnierse, Van Rijswijk 2011; 50 Yao, Yip, Shrader 2016; 55 Schulze, Kotter, Ernemann 2009; 192 Griggs, Askanas, Dimauro 1995; 38 Garcia 2000; 29 O'connell, Powell, Brennan 2002; 179 Valiyil, Casciola-Rosen, Hong 2010; 62 Dalakas 2015; 373 Mammen, Pak, Williams 2012; 64 Sontheimer 2002; 46 Dion, Cherin, Payan 2002; 29 Van De Vlekkert, Maas, Hoogendijk 2015; 51 Zheng, Liu, Wang 2015; 54 Tasca, Monforte, De Fino 2015; 52 Yoshida, Kurosaka, Joh 2010; 62 Papke, Wooldridge 1996; 11 Filli, Maurer, Manoliu 2015; 25 Tasca (10.1136/annrheumdis-2016-210198_bib7) 2015; 52 Sontheimer (10.1136/annrheumdis-2016-210198_bib10) 2002; 46 Efron (10.1136/annrheumdis-2016-210198_bib16) 1993 Filli (10.1136/annrheumdis-2016-210198_bib21) 2015; 25 Del Grande (10.1136/annrheumdis-2016-210198_bib2) 2011; 22 Cox (10.1136/annrheumdis-2016-210198_bib5) 2011; 50 Yao (10.1136/annrheumdis-2016-210198_bib17) 2016; 55 Dion (10.1136/annrheumdis-2016-210198_bib6) 2002; 29 Griggs (10.1136/annrheumdis-2016-210198_bib9) 1995; 38 Garcia (10.1136/annrheumdis-2016-210198_bib3) 2000; 29 Papke (10.1136/annrheumdis-2016-210198_bib15) 1996; 11 Yoshida (10.1136/annrheumdis-2016-210198_bib4) 2010; 62 Kuo (10.1136/annrheumdis-2016-210198_bib14) 2007; 19 Hoogendijk (10.1136/annrheumdis-2016-210198_bib8) 2004; 14 Bohan (10.1136/annrheumdis-2016-210198_bib11) 1975; 292 Schulze (10.1136/annrheumdis-2016-210198_bib19) 2009; 192 Dalakas (10.1136/annrheumdis-2016-210198_bib1) 2015; 373 O'connell (10.1136/annrheumdis-2016-210198_bib18) 2002; 179 Valiyil (10.1136/annrheumdis-2016-210198_bib13) 2010; 62 Mammen (10.1136/annrheumdis-2016-210198_bib12) 2012; 64 Van De Vlekkert (10.1136/annrheumdis-2016-210198_bib20) 2015; 51 Zheng (10.1136/annrheumdis-2016-210198_bib22) 2015; 54 |
References_xml | – volume: 50 start-page: 1153 year: 2011 article-title: Magnetic resonance imaging of skeletal muscles in sporadic inclusion body myositis publication-title: Rheumatology (Oxf) doi: 10.1093/rheumatology/ker001 – volume: 192 start-page: 1708 year: 2009 article-title: MRI findings in inflammatory muscle diseases and their noninflammatory mimics publication-title: AJR Am J Roentgenol doi: 10.2214/AJR.08.1764 – volume: 29 start-page: 425 year: 2000 article-title: MRI in inflammatory myopathies publication-title: Skeletal Radiol doi: 10.1007/s002560000238 – volume: 29 start-page: 1897 year: 2002 article-title: Magnetic resonance imaging criteria for distinguishing between inclusion body myositis and polymyositis publication-title: J Rheumatol – volume: 373 start-page: 393 year: 2015 article-title: Inflammatory muscle diseases publication-title: N Engl J Med doi: 10.1056/NEJMc1506827 – volume: 52 start-page: 956 year: 2015 article-title: Magnetic resonance imaging pattern recognition in sporadic inclusion-body myositis publication-title: Muscle Nerve doi: 10.1002/mus.24661 – volume: 14 start-page: 337 year: 2004 article-title: 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, the Netherlands publication-title: Neuromuscul Disord doi: 10.1016/j.nmd.2004.02.006 – volume: 19 start-page: 530 year: 2007 article-title: Skeletal muscle imaging and inflammatory myopathies publication-title: Curr Opin Rheumatol doi: 10.1097/BOR.0b013e3282efdc66 – volume: 179 start-page: 967 year: 2002 article-title: Whole-body MR imaging in the diagnosis of polymyositis publication-title: AJR Am J Roentgenol doi: 10.2214/ajr.179.4.1790967 – volume: 62 start-page: 1328 year: 2010 article-title: Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series publication-title: Arthritis Care Res (Hoboken) doi: 10.1002/acr.20219 – volume: 51 start-page: 253 year: 2015 article-title: Combining MRI and muscle biopsy improves diagnostic accuracy in subacute-onset idiopathic inflammatory myopathy publication-title: Muscle Nerve doi: 10.1002/mus.24307 – volume: 46 start-page: 626 year: 2002 article-title: Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? publication-title: J Am Acad Dermatol doi: 10.1067/mjd.2002.120621 – volume: 11 start-page: 619 year: 1996 article-title: Econometric methods for fractional response variables With an application to 401(K) plan participation rates publication-title: J Appl Econ doi: 10.1002/(SICI)1099-1255(199611)11:6<619::AID-JAE418>3.0.CO;2-1 – volume: 55 start-page: 441 year: 2016 article-title: Magnetic resonance measurement of muscle T2, fat-corrected T2 and fat fraction in the assessment of idiopathic inflammatory myopathies publication-title: Rheumatology (Oxf) doi: 10.1093/rheumatology/kev344 – volume: 292 start-page: 403 year: 1975 article-title: Polymyositis and dermatomyositis (second of two parts) publication-title: N Engl J Med doi: 10.1056/NEJM197502202920807 – volume: 25 start-page: 3499 year: 2015 article-title: Whole-body MRI in adult inflammatory myopathies: do we need imaging of the trunk? publication-title: Eur Radiol doi: 10.1007/s00330-015-3783-3 – volume: 38 start-page: 705 year: 1995 article-title: Inclusion body myositis and myopathies publication-title: Ann Neurol doi: 10.1002/ana.410380504 – volume: 22 start-page: 39 year: 2011 article-title: Magnetic resonance imaging of inflammatory myopathies publication-title: Top Magn Reson Imaging doi: 10.1097/RMR.0b013e31825b2c35 – volume: 62 start-page: 3751 year: 2010 article-title: Fasciitis as a common lesion of dermatomyositis, demonstrated early after disease onset by en bloc biopsy combined with magnetic resonance imaging publication-title: Arthritis Rheum doi: 10.1002/art.27704 – volume: 64 start-page: 269 year: 2012 article-title: Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects publication-title: Arthritis Care Res (Hoboken) doi: 10.1002/acr.20662 – volume: 54 start-page: 1017 year: 2015 article-title: Magnetic resonance imaging changes of thigh muscles in myopathy with antibodies to signal recognition particle publication-title: Rheumatology (Oxf) doi: 10.1093/rheumatology/keu422 – volume: 373 start-page: 393 year: 2015 ident: 10.1136/annrheumdis-2016-210198_bib1 article-title: Inflammatory muscle diseases publication-title: N Engl J Med doi: 10.1056/NEJMc1506827 – volume: 46 start-page: 626 year: 2002 ident: 10.1136/annrheumdis-2016-210198_bib10 article-title: Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? publication-title: J Am Acad Dermatol doi: 10.1067/mjd.2002.120621 – volume: 54 start-page: 1017 year: 2015 ident: 10.1136/annrheumdis-2016-210198_bib22 article-title: Magnetic resonance imaging changes of thigh muscles in myopathy with antibodies to signal recognition particle publication-title: Rheumatology (Oxf) doi: 10.1093/rheumatology/keu422 – volume: 22 start-page: 39 year: 2011 ident: 10.1136/annrheumdis-2016-210198_bib2 article-title: Magnetic resonance imaging of inflammatory myopathies publication-title: Top Magn Reson Imaging doi: 10.1097/RMR.0b013e31825b2c35 – volume: 50 start-page: 1153 year: 2011 ident: 10.1136/annrheumdis-2016-210198_bib5 article-title: Magnetic resonance imaging of skeletal muscles in sporadic inclusion body myositis publication-title: Rheumatology (Oxf) doi: 10.1093/rheumatology/ker001 – volume: 14 start-page: 337 year: 2004 ident: 10.1136/annrheumdis-2016-210198_bib8 article-title: 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, the Netherlands publication-title: Neuromuscul Disord doi: 10.1016/j.nmd.2004.02.006 – volume: 292 start-page: 403 year: 1975 ident: 10.1136/annrheumdis-2016-210198_bib11 article-title: Polymyositis and dermatomyositis (second of two parts) publication-title: N Engl J Med doi: 10.1056/NEJM197502202920807 – volume: 51 start-page: 253 year: 2015 ident: 10.1136/annrheumdis-2016-210198_bib20 article-title: Combining MRI and muscle biopsy improves diagnostic accuracy in subacute-onset idiopathic inflammatory myopathy publication-title: Muscle Nerve doi: 10.1002/mus.24307 – volume: 62 start-page: 3751 year: 2010 ident: 10.1136/annrheumdis-2016-210198_bib4 article-title: Fasciitis as a common lesion of dermatomyositis, demonstrated early after disease onset by en bloc biopsy combined with magnetic resonance imaging publication-title: Arthritis Rheum doi: 10.1002/art.27704 – volume: 52 start-page: 956 year: 2015 ident: 10.1136/annrheumdis-2016-210198_bib7 article-title: Magnetic resonance imaging pattern recognition in sporadic inclusion-body myositis publication-title: Muscle Nerve doi: 10.1002/mus.24661 – volume: 38 start-page: 705 year: 1995 ident: 10.1136/annrheumdis-2016-210198_bib9 article-title: Inclusion body myositis and myopathies publication-title: Ann Neurol doi: 10.1002/ana.410380504 – volume: 29 start-page: 425 year: 2000 ident: 10.1136/annrheumdis-2016-210198_bib3 article-title: MRI in inflammatory myopathies publication-title: Skeletal Radiol doi: 10.1007/s002560000238 – volume: 55 start-page: 441 year: 2016 ident: 10.1136/annrheumdis-2016-210198_bib17 article-title: Magnetic resonance measurement of muscle T2, fat-corrected T2 and fat fraction in the assessment of idiopathic inflammatory myopathies publication-title: Rheumatology (Oxf) – volume: 11 start-page: 619 year: 1996 ident: 10.1136/annrheumdis-2016-210198_bib15 article-title: Econometric methods for fractional response variables With an application to 401(K) plan participation rates publication-title: J Appl Econ doi: 10.1002/(SICI)1099-1255(199611)11:6<619::AID-JAE418>3.0.CO;2-1 – volume: 64 start-page: 269 year: 2012 ident: 10.1136/annrheumdis-2016-210198_bib12 article-title: Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects publication-title: Arthritis Care Res (Hoboken) doi: 10.1002/acr.20662 – volume: 62 start-page: 1328 year: 2010 ident: 10.1136/annrheumdis-2016-210198_bib13 article-title: Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series publication-title: Arthritis Care Res (Hoboken) doi: 10.1002/acr.20219 – volume: 192 start-page: 1708 year: 2009 ident: 10.1136/annrheumdis-2016-210198_bib19 article-title: MRI findings in inflammatory muscle diseases and their noninflammatory mimics publication-title: AJR Am J Roentgenol doi: 10.2214/AJR.08.1764 – volume: 25 start-page: 3499 year: 2015 ident: 10.1136/annrheumdis-2016-210198_bib21 article-title: Whole-body MRI in adult inflammatory myopathies: do we need imaging of the trunk? publication-title: Eur Radiol doi: 10.1007/s00330-015-3783-3 – volume: 19 start-page: 530 year: 2007 ident: 10.1136/annrheumdis-2016-210198_bib14 article-title: Skeletal muscle imaging and inflammatory myopathies publication-title: Curr Opin Rheumatol doi: 10.1097/BOR.0b013e3282efdc66 – volume: 29 start-page: 1897 year: 2002 ident: 10.1136/annrheumdis-2016-210198_bib6 article-title: Magnetic resonance imaging criteria for distinguishing between inclusion body myositis and polymyositis publication-title: J Rheumatol – year: 1993 ident: 10.1136/annrheumdis-2016-210198_bib16 – volume: 179 start-page: 967 year: 2002 ident: 10.1136/annrheumdis-2016-210198_bib18 article-title: Whole-body MR imaging in the diagnosis of polymyositis publication-title: AJR Am J Roentgenol doi: 10.2214/ajr.179.4.1790967 |
SSID | ssj0000818 |
Score | 2.5679164 |
Snippet | ObjectivesThe aims of this study were to define the pattern of muscle involvement in patients with immune-mediated necrotising myopathy (IMNM) relative to... The aims of this study were to define the pattern of muscle involvement in patients with immune-mediated necrotising myopathy (IMNM) relative to those with... Objectives The aims of this study were to define the pattern of muscle involvement in patients with immune-mediated necrotising myopathy (IMNM) relative to... |
SourceID | pubmedcentral proquest pubmed crossref bmj |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 681 |
SubjectTerms | Adiposity Adult Aged Antibodies - blood Atrophy - diagnostic imaging Biomarkers - blood Dermatomyositis - diagnostic imaging Edema Edema - diagnostic imaging Female Humans Hydroxymethylglutaryl CoA Reductases - immunology Kinases Magnetic Resonance Imaging Male Middle Aged Muscle, Skeletal - diagnostic imaging Muscle, Skeletal - pathology Muscular Diseases - blood Muscular Diseases - diagnostic imaging Muscular Diseases - immunology Myositis, Inclusion Body - diagnostic imaging Necrosis - blood Necrosis - diagnostic imaging Necrosis - immunology Patients Polymyositis - diagnostic imaging Predictive Value of Tests Severity of Illness Index Signal Recognition Particle - immunology Studies Thigh |
Title | Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity |
URI | http://ard.bmj.com/content/76/4/681.full https://www.ncbi.nlm.nih.gov/pubmed/27651398 https://www.proquest.com/docview/1882905442 https://www.proquest.com/docview/1835370836 https://www.proquest.com/docview/1881757601 https://pubmed.ncbi.nlm.nih.gov/PMC6019551 |
Volume | 76 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVPQU databaseName: Health & Medical Collection (Proquest) customDbUrl: eissn: 1468-2060 dateEnd: 20241231 omitProxy: true ssIdentifier: ssj0000818 issn: 0003-4967 databaseCode: 7X7 dateStart: 19390101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1468-2060 dateEnd: 20241231 omitProxy: true ssIdentifier: ssj0000818 issn: 0003-4967 databaseCode: BENPR dateStart: 19390101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1La9wwEBZtAqWXkr63eaBCb63o6mUpvZSmJKSFDWGbwN6MLMnEobbTXfuQ39I_2xmvvekmkBZ8sJFsC2Y0-kb6ZoaQd1EFqTLwToRLxkzluWDOg9dqIgew4cAlcRg7PDlJjs_V95me9Rtui55WOdjEzlCH2uMe-Udu8chPKyU-X_1iWDUKT1f7EhoPySYHqIJabWbmxhJbboeKeWo_MT2_i8uuyMv8IrZlKBagKDxh4PqA_w0rTFZerq9Rd4Dnbf7kXwvS0RZ50iNJ-mUp-qfkQayekUeT_qz8Ofl9hqmIadkuoJlOpt9oUdECw0Ei6-JFAGvSClBj3RS4YUDL6xrrE19_ot3OOPLaaR1DLN0HGjEP8vCt4EqwQtRVgSI5kdY53DcF-zE9pa5tanzIaqQnUgcXLZECNMdusAxHrJb3gpwfHZ59PWZ9KQaWaWsaZvwYhOml0kZZ6WzGhbBcGRCmyBMeco1-nM5MLlRQ1gsZtVQGfEWlo9dGviQbVV3F14SKLMjAPdiW3Cobk_2g4tjm3keZca_diLwHEaRXy2QbaeekyC5wehBYigJLlwIbkWQQVer7rOZYXOPnv18cr17873_tDLqQ9jN9kd7o5Yi8XTXDHMWDF1fFusU-UkuDecDv62MBySFDaUReLdVrNS5hEg1IHQZg1hRv1QFzhK-3VMVFlys8wYBQzd_cP_Rt8lggXOkYSTtko5m3cRfAVpPtdTNqj2weHJ6cTv8AYWgsFA |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELfGkIAXxH86BhgJniCi_hd7SAghYGrZOqHRSX0Lju1oQUsy2lSon4XvwGfkLk06CtLgZVIfWtlJT7rz-X727-4IeRqkFzIFdMJt3I9klvHIOkCtOjAINixAEou5w6ODeHAkP07UZIP87HJhkFbZ-cTGUfvK4Rn5S2bwyk9Jyd-cfouwaxTernYtNJZmsRcW3wGyzV4P34N-n3G--2H8bhC1XQWiVBldR9r1QS4npNLSCGtSxrlhUoNcPIuZzxRCEpXqjEsvjeMiKCE1wB6pglNawHsvkctS9CXW6tcTfeb5DTNdhz65E-uWT8ZE01Rmehzmhc9nYJgsjgBqAd6HHS0tvq7viX8Fun_yNX_bAHdvkOtt5ErfLk3tJtkI5S1yZdTezd8mP8ZY-pgW8xkM09HhkOYlzTH9JERNfgrEtrSEKLWqczygoMWiwn7Ii1e0OYlHHj2tgg-FfUED1l3u3uVtAV6P2tJTJEPSKoPvdR59PvxE7byu8EdaIR2SWvjQAilHU5wG237A7nx3yNGFKOku2SyrMtwnlKdeeObAl2VGmhDveBn6JnMuiJQ5ZXvkOaggOV0W90gaUCSaRO1OYQkqLFkqrEfiTlWJa6uoYzOPk38_2F89-N__td3ZQtJ6lllytg565MlqGHwCXvTYMlRznCOU0Fh3_Lw5BiJHZET1yL2lea3k4jpWgAxAAL1meKsJWJN8faTMj5va5DEmoCq2db7oj8nVwXi0n-wPD_YekGscQ6WGDbVNNuvpPDyEQK9OHzWri5IvF72cfwE5W2RA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELfGkCZeEP_pGGAkeIJo9b_YQ0IIMaqV0Wkam9S34NiOFrQko02F-ln4Jnw67tKkoyANXib1oZWd9KQ7n-9n_-6OkOdBeiFTQCfcxv1IZhmPrAPUqgODYMMCJLGYOzw6iPdO5MexGq-Rn10uDNIqO5_YOGpfOTwj32YGr_yUlHw7a2kRh7uDt-ffIuwghTetXTuNhYnsh_l3gG_TN8Nd0PULzgcfjt_vRW2HgShVRteRdn2Q0QmptDTCmpRxbpjUICPPYuYzhfBEpTrj0kvjuAhKSA0QSKrglBbw3mvkuhZSIJ1Mj_XFLmCY6br1yZ1Yt9wyJpoGM5PTMCt8PgUjZXEEsAuwP-xuafF1dX_8K-j9k7v522Y4uEVutlEsfbcwu9tkLZR3yMaovae_S34cYxlkWsymMExHR0OalzTHVJQQNbkqEOfSEiLWqs7xsIIW8wp7I89f0-ZUHjn1tAo-FPYVDViDuXuXtwV4QGpLT5EYSasMvtd59PnokNpZXeGPtEJqJLXwoQXSjyY4DUKAgJ367pGTK1HSfbJeVmV4SChPvfDMgV_LjDQh3vEy9E3mXBApc8r2yEtQQXK-KPSRNABJNEnbncISVFiyUFiPxJ2qEtdWVMfGHmf_frC_fPC__2urs4Wk9TLT5GJN9Miz5TD4B7z0sWWoZjhHKKGxBvllcwxEkciO6pEHC_NaysV1rAAlgAB6xfCWE7A--epImZ82dcpjTEZVbPNy0Z-SDVjIyafhwf4jcoNj1NQQo7bIej2ZhccQ89Xpk2ZxUfLlqlfzL_1QaHs |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Thigh+muscle+MRI+in+immune-mediated+necrotising+myopathy%3A+extensive+oedema%2C+early+muscle+damage+and+role+of+anti-SRP+autoantibodies+as+a+marker+of+severity&rft.jtitle=Annals+of+the+rheumatic+diseases&rft.au=Pinal-Fernandez%2C+Iago&rft.au=Casal-Dominguez%2C+Maria&rft.au=Carrino%2C+John+A&rft.au=Lahouti%2C+Arash+H&rft.date=2017-04-01&rft.issn=0003-4967&rft.eissn=1468-2060&rft.volume=76&rft.issue=4&rft.spage=681&rft_id=info:doi/10.1136%2Fannrheumdis-2016-210198&rft_id=info%3Apmid%2F27651398&rft.externalDBID=ard&rft.externalDocID=annrheumdis |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0003-4967&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0003-4967&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0003-4967&client=summon |